Clinical Trials in Whittier, United States
Locations / Whittier, United States
Delta Trials hosts 29 clinical trials conducted in Whittier, United States, making it a notable site of clinical research activity. These trials covering 162 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Whittier.
29
Total Trials
162
Conditions
0
Terminated since 2020
Browse by condition (162 total)
- Recurrent ovarian carcinoma 3 trialsAll Recurrent ovarian carcinoma trials
- Recurrent fallopian tube carcinoma 2 trialsAll Recurrent fallopian tube carcinoma trials
- Lung non-small cell carcinoma 2 trialsAll Lung non-small cell carcinoma trials
- Recurrent endometrial carcinoma 2 trialsAll Recurrent endometrial carcinoma trials
- Recurrent malignant solid neoplasm 2 trialsAll Recurrent malignant solid neoplasm trials
- Stage iiia lung cancer ajcc v8 2 trialsAll Stage iiia lung cancer ajcc v8 trials
- Refractory malignant solid neoplasm 2 trialsAll Refractory malignant solid neoplasm trials
- All Recurrent primary peritoneal carcinoma trials
- Stage iiib lung cancer ajcc v8 2 trialsAll Stage iiib lung cancer ajcc v8 trials
- All Lung non-squamous non-small cell carcinoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Advanced malignant solid neoplasm 2 trialsAll Advanced malignant solid neoplasm trials
- Invasive breast carcinoma 2 trialsAll Invasive breast carcinoma trials
- Metastatic malignant solid neoplasm 2 trialsAll Metastatic malignant solid neoplasm trials
- Stage ii lung cancer ajcc v8 2 trialsAll Stage ii lung cancer ajcc v8 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Refractory lymphoma 1 trialAll Refractory lymphoma trials
- All Stage iib lung non-small cell carcinoma ajcc v7 trials
- All Stage iii chronic lymphocytic leukemia trials